BIRD Fundamental Analysis - ALLBIRDS INC-CL A

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to BIRD. BIRD was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. BIRD has a great financial health rating, but its profitability evaluates not so good. BIRD does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

BIRD had negative earnings in the past year.

In the past year BIRD has reported a negative cash flow from operations.

BIRD had negative earnings in each of the past 5 years.

In the past 5 years BIRD always reported negative operating cash flow.

1.2 Ratios

BIRD has a worse Return On Assets (-59.67%) than 93.75% of its industry peers.

The Return On Equity of BIRD (-106.09%) is worse than 87.50% of its industry peers.

		Industry Rank	Sector Rank
ROA	-59.67%
ROE	-106.09%
ROIC	N/A

ROA(3y)-40.03%

ROA(5y)-28%

ROE(3y)-68.68%

ROE(5y)-46.4%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BIRD has a Gross Margin of 42.19%. This is in the lower half of the industry: BIRD underperforms 66.67% of its industry peers.

In the last couple of years the Gross Margin of BIRD has declined.

BIRD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	42.19%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.86%

GM growth 5Y-3.48%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BIRD does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for BIRD has been increased compared to 1 year ago.

The number of shares outstanding for BIRD has been reduced compared to 5 years ago.

There is no outstanding debt for BIRD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -4.15, we must say that BIRD is in the distress zone and has some risk of bankruptcy.

BIRD has a Altman-Z score of -4.15. This is amonst the worse of the industry: BIRD underperforms 91.67% of its industry peers.

There is no outstanding debt for BIRD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-4.15

ROIC/WACCN/A

WACC9.02%

2.3 Liquidity

BIRD has a Current Ratio of 3.21. This indicates that BIRD is financially healthy and has no problem in meeting its short term obligations.

BIRD's Current ratio of 3.21 is amongst the best of the industry. BIRD outperforms 87.50% of its industry peers.

A Quick Ratio of 1.80 indicates that BIRD should not have too much problems paying its short term obligations.

The Quick ratio of BIRD (1.80) is better than 83.33% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.21
Quick Ratio	1.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.25% over the past year.

Looking at the last year, BIRD shows a very negative growth in Revenue. The Revenue has decreased by -23.63% in the last year.

BIRD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.41% yearly.

EPS 1Y (TTM)22.25%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%19.71%

Revenue 1Y (TTM)-23.63%

Revenue growth 3Y-11.9%

Revenue growth 5Y-0.41%

Sales Q2Q%-18.34%

3.2 Future

The Earnings Per Share is expected to grow by 18.25% on average over the next years. This is quite good.

Based on estimates for the next years, BIRD will show a small growth in Revenue. The Revenue will grow by 1.04% on average per year.

EPS Next Y15.07%

EPS Next 2Y14.17%

EPS Next 3Y18.25%

EPS Next 5YN/A

Revenue Next Year-7.21%

Revenue Next 2Y-1.28%

Revenue Next 3Y1.04%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

BIRD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BIRD. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as BIRD's earnings are expected to grow with 18.25% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y14.17%

EPS Next 3Y18.25%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BIRD does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ALLBIRDS INC-CL A

NASDAQ:BIRD (6/20/2025, 8:17:59 PM)

After market: 10.5 0 (0%)

10.5

-0.71 (-6.33%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Durables & Apparel

GICS IndustryTextiles, Apparel & Luxury Goods

Earnings (Last)05-08 2025-05-08/amc

Earnings (Next)N/A N/A

Inst Owners38.15%

Inst Owner Change-0.87%

Ins Owners2.45%

Ins Owner Change1.62%

Market Cap84.63M

Analysts74.55

Price Target9.69 (-7.71%)

Short Float %17.19%

Short Ratio12.47

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)18.88%

Min EPS beat(2)7.68%

Max EPS beat(2)30.07%

EPS beat(4)4

Avg EPS beat(4)21.97%

Min EPS beat(4)7.68%

Max EPS beat(4)32.77%

EPS beat(8)8

Avg EPS beat(8)21.57%

EPS beat(12)12

Avg EPS beat(12)19.22%

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)1

Avg Revenue beat(2)1.46%

Min Revenue beat(2)-1.99%

Max Revenue beat(2)4.91%

Revenue beat(4)3

Avg Revenue beat(4)1.16%

Min Revenue beat(4)-1.99%

Max Revenue beat(4)4.91%

Revenue beat(8)5

Avg Revenue beat(8)0.26%

Revenue beat(12)7

Avg Revenue beat(12)0.17%

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-5%

PT rev (3m)5.56%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-11.33%

EPS NY rev (1m)0%

EPS NY rev (3m)9.68%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-15.18%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-3.3%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.46
P/FCF	N/A
P/OCF	N/A
P/B	1.02
P/tB	1.02
EV/EBITDA	N/A

EPS(TTM)-11.04

EYN/A

EPS(NY)-8.16

Fwd EYN/A

FCF(TTM)-8.58

FCFYN/A

OCF(TTM)-8.13

OCFYN/A

SpS22.65

BVpS10.28

TBVpS10.27

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-59.67%
ROE	-106.09%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	42.19%
FCFM	N/A

ROA(3y)-40.03%

ROA(5y)-28%

ROE(3y)-68.68%

ROE(5y)-46.4%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.86%

GM growth 5Y-3.48%

F-Score3

Asset Turnover1.24

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	38.25%
Cap/Sales	1.98%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.21
Quick Ratio	1.8
Altman-Z	-4.15

F-Score3

WACC9.02%

ROIC/WACCN/A

Cap/Depr(3y)99.47%

Cap/Depr(5y)150.28%

Cap/Sales(3y)5.66%

Cap/Sales(5y)6.44%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)22.25%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%19.71%

EPS Next Y15.07%

EPS Next 2Y14.17%

EPS Next 3Y18.25%

EPS Next 5YN/A

Revenue 1Y (TTM)-23.63%

Revenue growth 3Y-11.9%

Revenue growth 5Y-0.41%

Sales Q2Q%-18.34%

Revenue Next Year-7.21%

Revenue Next 2Y-1.28%

Revenue Next 3Y1.04%

Revenue Next 5YN/A

EBIT growth 1Y23.96%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year37.49%

EBIT Next 3Y22.17%

EBIT Next 5YN/A

FCF growth 1Y28.75%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y7.71%

OCF growth 3YN/A

OCF growth 5YN/A

ALLBIRDS INC-CL A (BIRD) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens